Related references
Note: Only part of the references are listed.Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes
Cedric Langhi et al.
FEBS LETTERS (2008)
The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice
Wei-Na Cong et al.
LIFE SCIENCES (2008)
Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy
Tao Jiang et al.
DIABETES (2007)
The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review
Michael H. Davidson
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Regulation of hepatic Insig-2 by the farnesoid X receptor
Melissa L. Hubbert et al.
MOLECULAR ENDOCRINOLOGY (2007)
Liver X receptor (LXR)-β regulation in LXRα-deficient mice:: Implications for therapeutic targeting
Elaine M. Quinet et al.
MOLECULAR PHARMACOLOGY (2006)
FXR, a multipurpose nuclear receptor
Florence Y. Lee et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Fenofibrate, a peroxisome proliferator-activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver
Yuichi Harano et al.
LIVER INTERNATIONAL (2006)
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
B Cariou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters
S Bilz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates
R Shiri-Sverdlov et al.
JOURNAL OF HEPATOLOGY (2006)
Farnesoid X receptor is essential for normal glucose homeostasis
K Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
YQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase promoter by nuclear receptors liver receptor homologue-1 and small heterodimer partner - A mechanism for differential regulation of cholesterol synthesis and uptake
S Datta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2)
DJ Shin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Guggulipid for the treatment of hypercholesterolemia - A randomized controlled trial
PO Szapary et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
T Claudel et al.
GASTROENTEROLOGY (2003)
Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump
J Cui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
G Lambert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Bile acids enhance low density lipoprotein receptor gene expression via a MAPK cascade-mediated stabilization of mRNA
M Nakahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A natural product that lowers cholesterol as an antagonist ligand for FXR
NL Urizar et al.
SCIENCE (2002)
Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors α and β
JJ Repa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Chemical genomics: Functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism
TM Willson et al.
MEDICINAL RESEARCH REVIEWS (2001)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
JJ Repa et al.
SCIENCE (2000)
Share Paper
